STARTUP PROFILE

Gestala

COUNTRY
China
FOUNDED
2026
CATEGORY
Brain-Computer Interface
Building a non-invasive ultrasound-based brain-computer interface platform for neuromodulation and neural signal decoding.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Ultrasound
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Pain/migraine
TARGET USER
Clinicians
REGULATORY STAGE
Preclinical
Gestala is developing ultrasound-based BCIs, aiming to combine non-invasive stimulation with neural decoding. It sits in an early-stage, experimental category alongside other ultrasound neurotech startups.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
4
Small Rounds, Big Results
23 June – 7 July 2026

Gestala formally opened its Shanghai headquarters and initiated the first phase of its Chengdu "super factory" on June 26, and then closed a RMB 420M (~$62M) round a week later. The financing was led by Huaying Capital, with Sequoia China and C Capital among the new backers. The funding brings the ultrasound BCI startup's total raised to roughly RMB 570M within six months of launch. Gestala's Chengdu site handles core R&D, clinical translation, and device production, while the Shanghai headquarters focuses on AI foundation models for the brain.

Articles featuring
Gestala